(Q42945326)

11 November 2017

title

Heterosubtypic immunity to influenza mediated by liposome adjuvanted H5N1 recombinant protein vaccines (English)

1 reference

11 November 2017

9

Wanpen Chaicumpa

1 reference

11 November 2017

6

Nitat Sookrung

1 reference

11 November 2017

Kanyarat Thueng-in

1

1 reference

11 November 2017

Santi Maneewatch

2

1 reference

11 November 2017

Potjanee Srimanote

3

1 reference

11 November 2017

Thaweesak Songserm

4

1 reference

11 November 2017

Pramuan Tapchaisri

5

1 reference

11 November 2017

Pongsri Tongtawe

7

1 reference

11 November 2017

Sunee Channarong

8

1 reference

11 November 2017

language of work or name

English

0 references

publication date

3 August 2010

1 reference

full work available at URL

11 November 2017

https://api.elsevier.com/content/article/PII:S0264410X10010765?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.07.065

https://api.elsevier.com/content/article/PII:S0264410X10010765?httpAccept=text/plain

17 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.07.065

17 June 2024

1 reference

11 November 2017

volume

28

1 reference

11 November 2017

issue

41

1 reference

11 November 2017

page(s)

6765-6777

1 reference

Influenza vaccine strain selection and recent studies on the global migration of seasonal influenza viruses

11 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

Variable efficacy of repeated annual influenza vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

Avian influenza virus (H5N1): a threat to human health.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

Avian influenza H5N1: risks at the human-animal interface.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

Evolutionary and transmission dynamics of reassortant H5N1 influenza virus in Indonesia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

Evolutionarily conserved protein sequences of influenza a viruses, avian and human, as vaccine targets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

Variation of influenza A, B, and C viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

Nuclear import of influenza virus RNA can be mediated by viral nucleoprotein and transport factors required for protein import

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

Unpacking the incoming influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

Keeping the viral coat on

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

Influenza virus proton channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

A fused gene of nucleoprotein (NP) and herpes simplex virus genes (VP22) induces highly protective immunity against different subtypes of influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

A universal influenza A vaccine based on the extracellular domain of the M2 protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

A "universal" human influenza A vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

Universal influenza A vaccine: optimization of M2-based constructs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

Vaccination of pigs with a DNA construct expressing an influenza virus M2-nucleoprotein fusion protein exacerbates disease after challenge with influenza A virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

Toxicity of influenza A virus matrix protein 2 for mammalian cells is associated with its intrinsic proton-channeling activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

Inhibition of influenza M2-induced cell death alleviates its negative contribution to vaccination efficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

Domestic ducks and H5N1 influenza epidemic, Thailand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

New strain of influenza A virus (H5N1), Thailand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

Universal primer set for the full-length amplification of all influenza A viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

Human monoclonal ScFv neutralize lethal Thai cobra, Naja kaouthia, neurotoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

Human single chain monoclonal antibody that recognizes matrix protein of heterologous influenza A virus subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

Cytokine profile during latent and slowly progressive primary tuberculosis: a possible role for interleukin-15 in mediating clinical disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

DNA microarray gene expression profile of T cells with the splice variants of TCRzeta mRNA observed in systemic lupus erythematosus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

Evaluation of canarypox-induced CD8(+) responses following immunization by measuring the effector population IFNgamma production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

Gamma interferon expression in CD8(+) T cells is a marker for circulating cytotoxic T lymphocytes that recognize an HLA A2-restricted epitope of human cytomegalovirus phosphoprotein pp65.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

Liposomal malaria vaccine in humans: a safe and potent adjuvant strategy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

Liposomal immunisation against snake venoms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

Use of liposomes for protective immunisation in sheep against Echis carinatus snake venom.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

Encapsulation of native crotoxin in liposomes: a safe approach for the production of antivenom and vaccination against Crotalus durissus terrificus venom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

Lipid vesicle size of an oral influenza vaccine delivery vehicle influences the Th1/Th2 bias in the immune response and protection against infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

Selective development of T helper (Th)2 cells induced by continuous administration of low dose soluble proteins to normal and beta(2)-microglobulin-deficient BALB/c mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

Role of particle size in phagocytosis of polymeric microspheres

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

Endotoxin limits in formulations for preclinical research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

Control of mucosal virus infection by influenza nucleoprotein-specific CD8+ cytotoxic T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

Evolution of the nucleoprotein gene of influenza A virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

7 January 2021

Evolutionary analysis of the influenza A virus M gene with comparison of the M1 and M2 proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

7 January 2021

Protective CD4+ and CD8+ T cells against influenza virus induced by vaccination with nucleoprotein DNA

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

7 January 2021

Passively transferred monoclonal antibody to the M2 protein inhibits influenza A virus replication in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

7 January 2021

Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.07.065

7 January 2021

Cytotoxic T lymphocytes induced by liposomal antigens: mechanisms of immunological presentation

53

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2010.07.065

17 June 2024

Identifiers

1 reference

11 November 2017

1 reference